Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Lyra Therapeutics CEO and leadership

Zippia score 4.2
OverviewJobsRevenue

Reviews

CEO & Executives

Lyra Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Richard Jezykowski is the Lyra Therapeutics's CEO. Lyra Therapeutics has 60 employees, of which 28 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Lyra Therapeutics executive team is 39% female and 61% male.
  • 72% of the management team is White.
  • 8% of Lyra Therapeutics management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at Lyra Therapeutics?
Share your experience

Rate Lyra Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Richard Jezykowski

Chief Executive Officer

Richard Jezykowski is a Chief Executive Officer at Lyra Therapeutics Inc and is based in Riverview, Florida.

Robert Langer

Board Member

George Whitesides

Founder

Jeffrey Carbeck

Co-Founder and Chief Technology Officer

Jeffrey Carbeck is a Co-Founder and Chief Technology Officer at Lyra Therapeutics Inc and is based in Cambridge, Cambridgeshire, United Kingdom.

Maria Palasis Ph.d

Board Member

Maria Palasis Ph.d's LinkedIn

Maria Palasis is an industry veteran in merging material science and drug-delivery innovation to create best-in-class therapies for patients.She brings nearly 25 years of healthcare industry experience to Lyra. A repeat entrepreneur, her transformative leadership as CEO, and previously CTO, of 480 Biomedical and Arsenal Medical resulted in >$160 million of external and non-dilutive funding and the advancement of multiple programs into the clinic. Earlier in her career, she managed a portfolio of external biotech and medical device investments at Boston Scientific and led the development of several combination therapies. She is an inventor on more than 120 issued and pending patents. Maria received her B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.

Harlan W. Waksal

Executive Chairman

Robert Kern

Chief Medical Officer

Robert Kern is a Chairman & Professor:Otolaryngology at Northwestern University Feinberg School of Medicine and Chief Medical Officer at Lyra Therapeutics Inc. He works or has worked as PRESIDENT at International Society of Inflammation and Allergy of the Nos. Robert attended Thomas Jefferson University and Georgetown University.

Corinne Noyes

Senior Vice President of Commercial Strategy & Market Development

Corinne Noyes's LinkedIn

Pamela Nelson

Senior Vice President of Regulatory Affairs

Robert Richard Ph.d

Senior Vice President-Technical Operations

Do you work at Lyra Therapeutics?

Does the leadership team provide a clear direction for Lyra Therapeutics?

Lyra Therapeutics jobs

Lyra Therapeutics founders

Name & TitleBio
Robert Langer

Board Member

George Whitesides

Founder

Jeffrey Carbeck

Co-Founder and Chief Technology Officer

Jeffrey Carbeck is a Co-Founder and Chief Technology Officer at Lyra Therapeutics Inc and is based in Cambridge, Cambridgeshire, United Kingdom.

Lyra Therapeutics board members

Name & TitleBio
Robert Langer

Board Member

Maria Palasis Ph.d

Board Member

Maria Palasis Ph.d's LinkedIn

Maria Palasis is an industry veteran in merging material science and drug-delivery innovation to create best-in-class therapies for patients.She brings nearly 25 years of healthcare industry experience to Lyra. A repeat entrepreneur, her transformative leadership as CEO, and previously CTO, of 480 Biomedical and Arsenal Medical resulted in >$160 million of external and non-dilutive funding and the advancement of multiple programs into the clinic. Earlier in her career, she managed a portfolio of external biotech and medical device investments at Boston Scientific and led the development of several combination therapies. She is an inventor on more than 120 issued and pending patents. Maria received her B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.

Harlan W. Waksal

Executive Chairman

Robert Kern

Chief Medical Officer

Robert Kern is a Chairman & Professor:Otolaryngology at Northwestern University Feinberg School of Medicine and Chief Medical Officer at Lyra Therapeutics Inc. He works or has worked as PRESIDENT at International Society of Inflammation and Allergy of the Nos. Robert attended Thomas Jefferson University and Georgetown University.

C. Ann Merrifield

Board Member

C. Ann Merrifield's LinkedIn

Edward Thomas Anderson

Board Member

Edward Thomas Anderson's LinkedIn

Konstantin Poukalov

Board Member

Konstantin Poukalov's LinkedIn

Michael R. Altman

Board Member

Michael R. Altman's LinkedIn

Nancy L. Snyderman

Board Member

W. Bradford Smith

Board Member

W. Bradford Smith's LinkedIn

Lyra Therapeutics executives FAQs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Lyra Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lyra Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Lyra Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lyra Therapeutics. The data presented on this page does not represent the view of Lyra Therapeutics and its employees or that of Zippia.

Lyra Therapeutics may also be known as or be related to LYRA THERAPEUTICS, INC., Lyra Therapeutics and Lyra Therapeutics, Inc.